Stock listing
NASDAQ:ACXP Acurx Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of Acurx Pharmaceuticals, Inc.
Follow Acurx Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ACXP
$1.04 USD -0.03 (-2.8%)
Close on Oct 30, 2026
- Day range
- $1.04 – $1.10 USDOct 30, 2026
- Volume
- 63,193 sharesOct 30, 2026
- Market cap
- $5.69M USDAt the close on Oct 30, 2026 · price × 5.47M shares outstanding
- 52-week range
- $1.04 – $7.54 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $166,500 USDMedian day 82,299 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ACXP · Home | $1.04 USD | -0.03 (-2.8%) | 63,193 | $1.09 | $1.103 | $1.035 | $1.07 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ACXP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.04 | -0.03 | -2.8% | $1.09 | $1.103 | $1.035 | 63,193 | |
| $1.07 | 0.00 | 0.0% | $1.06 | $1.11 | $1.06 | 64,574 | |
| $1.07 | +0.01 | +0.9% | $1.08 | $1.08 | $1.05 | 61,179 | |
| $1.06 | -0.025 | -2.3% | $1.08 | $1.096 | $1.05 | 58,323 | |
| $1.085 | -0.05 | -4.4% | $1.12 | $1.135 | $1.081 | 64,135 | |
| $1.135 | -0.005 | -0.4% | $1.135 | $1.14 | $1.12 | 22,151 | |
| $1.14 | -0.01 | -0.9% | $1.16 | $1.185 | $1.14 | 26,544 | |
| $1.15 | +0.01 | +0.9% | $1.18 | $1.18 | $1.13 | 20,961 | |
| $1.14 | 0.00 | 0.0% | $1.16 | $1.18 | $1.115 | 68,303 | |
| $1.14 | +0.04 | +3.6% | $1.14 | $1.146 | $1.10 | 51,098 | |
| $1.10 | -0.07 | -6.0% | $1.18 | $1.19 | $1.069 | 164,832 | |
| $1.17 | +0.02 | +1.7% | $1.20 | $1.219 | $1.15 | 101,503 | |
| $1.15 | -0.05 | -4.2% | $1.20 | $1.22 | $1.15 | 87,573 | |
| $1.20 | -0.08 | -6.3% | $1.29 | $1.29 | $1.20 | 99,674 | |
| $1.28 | +0.01 | +0.8% | $1.28 | $1.30 | $1.25 | 80,819 | |
| $1.27 | +0.02 | +1.6% | $1.24 | $1.28 | $1.24 | 41,145 | |
| $1.25 | -0.05 | -3.8% | $1.281 | $1.281 | $1.24 | 74,937 | |
| $1.30 | -0.01 | -0.8% | $1.32 | $1.33 | $1.28 | 78,042 | |
| $1.31 | 0.00 | 0.0% | $1.30 | $1.33 | $1.28 | 42,200 | |
| $1.31 | +0.04 | +3.1% | $1.25 | $1.36 | $1.25 | 110,872 | |
| $1.27 | +0.01 | +0.8% | $1.28 | $1.28 | $1.245 | 82,492 | |
| $1.26 | 0.00 | 0.0% | $1.27 | $1.295 | $1.25 | 64,944 | |
| $1.26 | -0.045 | -3.4% | $1.32 | $1.32 | $1.23 | 130,517 | |
| $1.305 | -0.035 | -2.6% | $1.38 | $1.38 | $1.27 | 162,116 | |
| $1.34 | -0.02 | -1.5% | $1.36 | $1.36 | $1.33 | 52,785 | |
| $1.36 | 0.00 | 0.0% | $1.38 | $1.38 | $1.35 | 134,020 | |
| $1.36 | -0.01 | -0.7% | $1.39 | $1.39 | $1.345 | 48,071 | |
| $1.37 | +0.01 | +0.7% | $1.36 | $1.385 | $1.35 | 58,697 | |
| $1.36 | +0.03 | +2.3% | $1.34 | $1.391 | $1.305 | 156,188 | |
| $1.33 | -0.06 | -4.3% | $1.39 | $1.41 | $1.31 | 280,635 | |
| $1.39 | 0.00 | 0.0% | $1.36 | $1.419 | $1.36 | 57,399 | |
| $1.39 | +0.01 | +0.7% | $1.386 | $1.41 | $1.38 | 70,433 | |
| $1.38 | +0.025 | +1.8% | $1.37 | $1.39 | $1.36 | 61,268 | |
| $1.355 | -0.035 | -2.5% | $1.39 | $1.40 | $1.35 | 82,106 | |
| $1.39 | -0.01 | -0.7% | $1.40 | $1.42 | $1.38 | 84,352 | |
| $1.40 | 0.00 | 0.0% | $1.41 | $1.41 | $1.38 | 64,705 | |
| $1.40 | -0.01 | -0.7% | $1.41 | $1.425 | $1.38 | 58,784 | |
| $1.41 | -0.02 | -1.4% | $1.413 | $1.43 | $1.41 | 32,569 | |
| $1.43 | +0.01 | +0.7% | $1.41 | $1.46 | $1.41 | 88,565 | |
| $1.42 | +0.02 | +1.4% | $1.40 | $1.42 | $1.39 | 47,678 | |
| $1.40 | -0.03 | -2.1% | $1.42 | $1.42 | $1.39 | 51,590 | |
| $1.43 | +0.03 | +2.1% | $1.41 | $1.44 | $1.40 | 82,532 | |
| $1.40 | -0.05 | -3.4% | $1.43 | $1.43 | $1.38 | 109,675 | |
| $1.45 | +0.01 | +0.7% | $1.44 | $1.45 | $1.40 | 111,676 | |
| $1.44 | -0.02 | -1.4% | $1.47 | $1.47 | $1.42 | 69,740 | |
| $1.46 | +0.03 | +2.1% | $1.43 | $1.479 | $1.42 | 86,862 | |
| $1.43 | +0.02 | +1.4% | $1.42 | $1.46 | $1.39 | 146,082 | |
| $1.41 | +0.01 | +0.7% | $1.41 | $1.445 | $1.40 | 87,729 | |
| $1.40 | -0.07 | -4.8% | $1.47 | $1.49 | $1.395 | 132,653 | |
| $1.47 | +0.02 | +1.4% | $1.45 | $1.53 | $1.45 | 84,594 | |
| $1.45 | +0.01 | +0.7% | $1.41 | $1.46 | $1.39 | 132,202 | |
| $1.44 | 0.00 | 0.0% | $1.45 | $1.489 | $1.37 | 269,230 | |
| $1.44 | -0.21 | -12.7% | $1.57 | $1.65 | $1.405 | 267,703 | |
| $1.65 | +0.255 | +18.3% | $1.40 | $1.817 | $1.388 | 1,103,649 | |
| $1.395 | -0.085 | -5.7% | $1.43 | $1.44 | $1.31 | 613,887 | |
| $1.48 | -0.06 | -3.9% | $1.55 | $1.59 | $1.42 | 268,594 | |
| $1.54 | +0.07 | +4.8% | $1.52 | $1.61 | $1.495 | 169,430 | |
| $1.47 | -0.06 | -3.9% | $1.58 | $1.63 | $1.46 | 104,160 | |
| $1.53 | -0.01 | -0.6% | $1.53 | $1.54 | $1.50 | 75,660 | |
| $1.54 | +0.08 | +5.5% | $1.47 | $1.60 | $1.45 | 113,324 | |
| $1.46 | -0.01 | -0.7% | $1.46 | $1.47 | $1.43 | 65,495 | |
| $1.47 | +0.04 | +2.8% | $1.46 | $1.47 | $1.41 | 48,616 | |
| $1.43 | 0.00 | 0.0% | $1.45 | $1.48 | $1.385 | 107,704 | |
| $1.43 | -0.01 | -0.7% | $1.455 | $1.47 | $1.35 | 197,705 | |
| $1.44 | +0.02 | +1.4% | $1.44 | $1.44 | $1.38 | 27,410 | |
| $1.42 | +0.03 | +2.2% | $1.42 | $1.42 | $1.345 | 109,854 |
- Ticker
- NASDAQ:ACXP
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 26, 2026
Acurx Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 12, 2026 Conference Call and Provide Business Update
Latest earnings call · Aug 14, 2026
Acurx Pharmaceuticals (NASDAQ:ACXP) Q2 2026 Earnings Call
Replay and transcript
Calls
Upcoming
Acurx Pharmaceuticals (NASDAQ:ACXP) Q3 2026 Earnings Call
Thu, Nov 12, 2026 · 4:00 PM ET
Register
Replays
Acurx Pharmaceuticals (NASDAQ:ACXP) Q2 2026 Earnings Call
Fri, Aug 14, 2026 · 8:00 AM ET
Watch TranscriptAcurx Pharmaceuticals (NASDAQ:ACXP) Q1 2026 Earnings Call
Tue, May 12, 2026 · 8:00 AM ET
Watch TranscriptAcurx Pharmaceuticals (NASDAQ:ACXP) Q4 2025 Earnings Call
Fri, Mar 13, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Acurx Pharmaceuticals to Discuss Third Quarter 2026 Financial Results on November 12, 2026 Conference Call and Provide Business Update
Oct 26, 2026
Closed $1.09 (-4.4%) on Oct 26, 2026
Acurx Announces Publication in ASM Confirming Data on its DNA pol IIIC Inhibitor Pipeline of Antibiotics Demonstrating a Potential Microbiome-Sparing Class Effect
Oct 21, 2026
Closed $1.15 (+0.9%) on Oct 21, 2026
Acurx Pharmaceuticals Takes Its Antibiotics Story Global Through a 12-Month Series with New to The Street
Oct 5, 2026
Closed $1.31 (+3.1%) on Oct 5, 2026
Acurx Pharmaceuticals Announces First Patient Enrolled in PATHFINDER Clinical Trial of Ibezapolstat in Multiply-Recurrent C. difficile Infection
Sep 29, 2026
Closed $1.31 (-2.6%) on Sep 29, 2026
Acurx Announces Presentation of a Scientific Poster at the Premier International C. difficile Symposium (ICDS) Demonstrating Superior In Vitro Kill Kinetics of Ibezapolstat vs. Vancomycin and Fidaxomicin (Standards of Care) in Clostridioides difficile and Vancomycin-Resistant Enterococcus Co-Cultures
Sep 14, 2026
Closed $1.39 (-0.7%) on Sep 14, 2026
Acurx Pharmaceuticals Receives FDA Conditional Acceptance and USPTO Trademark Allowance for the Company's Brand Name for Ibezapolstat
Aug 17, 2026
Closed $1.65 (+18.3%) on Aug 17, 2026
Acurx Pharmaceuticals, Inc. Reports Second Quarter 2026 results and provides business update
Aug 14, 2026
Closed $1.40 (-5.7%) on Aug 14, 2026
Japan and Mexico Patent Offices Both Grant Acurx Pharmaceuticals New Patents for DNA Polymerase IIIC Inhibitor Antibiotics
Aug 12, 2026
Closed $1.54 (+4.8%) on Aug 12, 2026
Acurx Announces Scientific Partnership with Leiden University Medical Center to Advance Development of Acurx's DNA Polymerase IIIC Inhibitor Antibiotics
Aug 10, 2026
Closed $1.53 (-0.6%) on Aug 10, 2026
FDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of Recurrence of C. difficile Infection
Aug 3, 2026
Closed $1.43 (-0.7%) on Aug 3, 2026
Decks
IDWeek 2025
Conference · 10 slides · Oct 20, 2025
Investor Presentation (September 2025)
Investor deck · 23 slides · September 2025
Technical Presentation (June 2025)
Technical · 10 slides · Jun 5, 2025
Peggy Lillis Foundation Inaugural CDI Scientific Symposium 2024
Conference · 19 slides · November 2024
Acurx Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 29 in the last 12 months · 123 in all · newest Oct 26, 2026 · oldest 2021
- Calls
- 12 calls with a replay · 12 with a transcript · latest Aug 14, 2026
- Decks
- 16 decks · latest Oct 20, 2025
Where Acurx Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ACXP · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ACXP | BOATS | United States | USD |
| gettex:3ZO0 | gettex | Germany | EUR |
| LS Exchange:A41DXH | LS Exchange | Germany | EUR |
| Frankfurt:3ZO0 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A41DXH | Lang & Schwarz | Germany | EUR |
| Munich:3ZO0 | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Acurx Pharmaceuticals, Inc.